Intratumoral injection for infant maxillofacial hemangioma
- VernacularTitle:瘤内注射治疗婴幼儿颌面部血管瘤
- Author:
Xinjing DONG
- Publication Type:Journal Article
- Keywords:
Triamcinolone Acetonide Acetate;
Pingyangmycin;
Intratumoral Injection;
Hemangioma
- From:
Journal of Chongqing Medical University
2003;0(06):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe and summarize the therapeutic effects of intratumoral injection with Triamcinolone Acetonide Acetate and Pingyangmycin on infant maxillofacial hemangioma.Methods:Local injection with Triamcinolone Acetonide Acetate(TAA)and Pingyangmycin(PYM)was executed to treat infant maxillofacial hemangioma.If the lesion did not disappear,the treatment would be performed again every four to six weeks at intervals,and the total dose of TAA and PYM could not be more than 100mg and 40mg respectively.The injection treatment was repeated 4 times for one course and the therapeutic effects of maxillofacial hemangioma were detected.Results: 84 cases with maxillofacial hemangioma,treated by local injection with TAA and PYM,had been followed up for one to three years.The cure rate was 90.4%,the notable rate was 7.1%,and the ineffective rate was 2.4%.Conclusions:The intratumoral injection with Triamcinolone Acetonide Acetate and Pingyangmycin is the reliable therapy method with less side effects.It is valuable for treatment of infant maxillofacial hemangioma.
